Skip to main content

An update on Health Care Reform

Oh how I'd love to have a good vent about this - but I'm so swamped with trying to work with Donna and the office on the HPS Conference, that I just haven't had the mental energy to tackle it. This is another summary from the American Thoracic Society's newsletter. It's very brief. I chose it becasue they write a nice summary. Keep in mind it is a summary though.



Health Care Reform - What Next?
While House and Senate Democratic leaders are still scrambling to make sense of Sen-Elect Brown's victory in Massachusetts, it is clear that the election results will have a significant impact on the health reform legislation. Prior to the special election on Massachusetts, Congress appeared headed towards tweaking the Senate health reform bill and attempting to pass the bill before President Obama's State of the Union address.


Now both House and Senate Democratic leaders are appear to have abandoned the Senate bill and are considering a number of other options, ranging from passing only those provisions that have bipartisan support, to using budget reconciliation (which requires only 51 votes) to passing the more controversial elements of health reform, to restarting the process from scratch, to giving up all together.
House Democratic leaders are currently considering a two-step plan to scale back the reform legislation and pass budget-related measures through the budget reconciliation process, which requires only a simple majority vote in the Senate and a series of smaller individual bills on issues such as insurance regulations.
The issues that are under consideration for inclusion in smaller bills are insurance regulations that have some support among Republicans, such as a prohibition on coverage denials based on pre-existing conditions, eliminating lifetime and annual caps and prohibiting insurance companies from rescinding coverage when individuals become sick. Medical malpractice reform, transitioning provider payments to a value-based system and expanding coverage through tax credits are also being discussed. The House Democratic leadership has not yet commented on these proposals, so it appears that it will be a few more days at least before a clear House-Senate strategy on health reform emerges.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria